Discontinued — last reported Q3 '24
Thermo Fisher Scientific All Other Countries — Total revenues decreased by 0.0% to $5.19B in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 2.1%, from $5.08B to $5.19B. Over 2 years (FY 2021 to FY 2023), All Other Countries — Total revenues shows an upward trend with a 11.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests successful market penetration or expansion in secondary international territories, while a decrease may indicate regional economic headwinds or a strategic shift in global sales focus.
This metric represents the total revenue generated from geographic regions outside of the company's primary reporting ma...
Peers typically report this as 'Rest of World' or 'Other International' revenue, and it is often used to gauge the diversification of a company's global revenue base.
tmo_segment_other_total_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.12B | $3.95B | $4.55B | $4.81B | $4.12B | $3.94B | $4.43B | $4.25B | $4.30B | $5.08B | $7.21B | $5.02B | $5.19B | $5.19B |
| QoQ Change | — | -4.2% | +15.1% | +5.8% | -14.3% | -4.5% | +12.6% | -4.0% | +1.1% | +18.2% | +41.8% | -30.3% | +3.4% | -0.0% |
| YoY Change | — | — | — | — | -0.0% | -0.4% | -2.5% | -11.6% | +4.3% | +29.2% | +62.6% | +18.1% | +20.8% | +2.1% |